Press release
Anti-cancer Drugs Market Worldwide Industry Volume By Region 2016 - 2024
The World Cancer Research Fund states that in 2012, there were around 14 million new cases of cancer around the world; of these, women accounted for 6.7 million cases and men accounted for 7.4 million cases. This figure is likely to increase to 24 million by 2035. Similarly, according to the World Health Organization, an estimated 8.2 million deaths in 2012 were directly related to cancer and the number of new cancer cases is anticipated to increase by an estimated 70% over the next two decades. Accounting for 13% of the total number of new cases diagnosed in 2012, lung cancer was the most common cancer across the globe, followed by breast cancer (1.7 million new cases), and colorectal cancer (1.4 million new cases).
Cancer mortality can be reduced if the disease is detected and treated early. Timely and correct diagnosis is key to effective and adequate treatment. Today, the global anti-cancer drugs market can be rightly characterized by the enormous amount of innovation that hopes to transform the landscape for patients, providers, and companies alike. SEER (Surveillance, Epidemiology, and End Results) survival statistics reveal that in 1990, only half of all cancer patients lived for five years after diagnosis. This has now increased to two-thirds, a result of gradual but consistent innovation in the anti-cancer drugs market.
Obtain Report Details @
http://www.transparencymarketresearch.com/anticancer-drugs-market.html
This research report serves as a blueprint for all stakeholders in the anti-cancer drugs market as it not only gives them a fresh, objective, and accurate perspective of the global industry but also examines the key factors governing its growth from 2016 to 2024, the report’s forecast period. Leading trends, forces driving the growth, and challenges that lie ahead have been discussed at length, supported by appropriate statistics and inputs from industry experts.
Global Anti-cancer Drugs Market: Key Trends and Opportunities
The rising global incidence of various cancers, including cancer of the breast, prostate, skin, blood, gastrointestinal tract, and lungs, is the primary factor boosting the demand for anti-cancer drugs. In addition to this, the development of advanced therapeutic modalities, such as targeted therapies, chemotherapy, immunotherapy, and hormonal therapies has significantly benefited the anti-cancer drugs market in recent years.
This market is predicted to benefit from the commercialization of follow-on-biologics and patent expiration of several blockbuster drugs. The threat of failure of the drugs, the high cost involved in the development of anti-cancer drugs, and the possible side effects of these drugs are expected to challenge the expansion of the global market in the coming years. However, rising government funds are likely to reduce the negative impact of these obstacles and continue propelling the anti-cancer drugs market.
Global Anti-cancer Drugs Market: Competitive Landscape and Region-wise Outlook
Some of the most prominent players in the global anti-cancer drugs market are Celgene Corporation, Eli Lilly and Company, Roche Diagnostics, Novartis AG, Pfizer, Sanofi, Amgen Inc., GlaxoSmithKline PLC, Merck & Company, and Johnson and Johnson.
Geographically, the international market for anti-cancer drugs is segmented into North America, Europe, Asia Pacific, and Rest of the World. North America presently surpasses all of the aforementioned regional markets and is likely to retain its leading position throughout the duration of the forecast period. Favorable reimbursement policies, the surge in investments by prominent multinational companies in the research as well as development of anti-cancer drugs, and the high adoption rate of immunotherapies are some of the major factors responsible for the growth of the North America anti-cancer drugs market.
Asia Pacific has been identified as a rather lucrative region for the anti-cancer drugs market owing to the rising awareness regarding the availability of advanced therapies. The increase in healthcare expenditure and per capita disposable income is also likely to contribute toward the future expansion of the Asia Pacific anti-cancer drugs market.
Fill the form for an exclusive sample of this report @
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12458
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We have an experienced team of Analysts, Researchers, and Consultants, who us e proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
Browse market research blog:
https://tmrresearch.blogspot.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-cancer Drugs Market Worldwide Industry Volume By Region 2016 - 2024 here
News-ID: 566189 • Views: …
More Releases from TMR - Healthcare
Clinical Trial Management System (CTMS) Market : Projection of Each Major Segmen …
With companies long having realized that the best way to remain competitive in the pharmaceutical industry is by ploughing back of profits into R&D projects, the demand for clinical trial management systems is expected to see an uptick. While this will help impel the market greatly in the coming years, what also needs to be taken into consideration that the cost of implementing such a system may deter investment decisions.
The…
Electronic Health Records Market : Industry Analysis and Detailed Profiles of to …
The global market for electronic health record (EHR) features a largely fragmented vendor landscape, with the presence of a large number of small and large players and the top five companies cumulatively accounting for a nearly 44% of the overall market in 2016. Leading vendors in the global EHR market are adopting inorganic growth strategies such as mergers and acquisitions to expand their reach across high-growth potential regional markets, consolidate…
Fuel Oil Market Intelligence Report Offers Growth Prospects
The global transportation industry has been growing at a significant pace since the past decade. Companies operating in the transportation industry are the largest consumers of the fuel oil. Apart from this, fuel oil also finds application in the petrochemical industry and petroleum refineries. The building materials industry is also on the rise since many years. The demand for fuel oil is expected to increase from the building materials industry.…
Thermoset Resin Market Global Industry Analysis, Trends and Forecast, 2016 - 202 …
The global composite industry has been expanding significantly in terms of production, technological advancements, and developments. Thermoset resin plays a vital role in the composite industry. Thermoset resins are used extensively in the manufacture of composites; these resins are employed in the fabrication of products for end-use industries such as aerospace, automotive, sporting goods, construction, electronics, and wind energy. The thermoset resin market can be segmented into six resin types:…
More Releases for Drugs
Generic Drugs Market Application Anti-Infective Drugs, Anti-Arthritis Drugs, Ant …
Generic drugs are the medications that are developed to be similar to a medicine that is already commercially available in the market with a brand name. The generic drug is similar to the medicine available in terms of dosage, safety and strength, mode of administration, quality and intended use. Due to the similarities, generic drugs are capable of treating various diseases. Generic drugs are most cost effective than the branded…
Cytotoxic Drugs Market Growing Demand for Antimetabolite Drugs
According to Precision Business Insights (PBI), the latest report, the cytotoxic drugs market is expected to be valued at USD 15,927.2 million in 2022 and is poised to grow at a significant CAGR of 2.2% over 2022-2028. The primary drivers of the expansion of the global cytotoxic drugs market include the increasing prevalence of cancer diseases, the increasing use and approval of cytotoxic drugs, and the increasing consumption of alcohol…
Global Antithrombotic Drugs Market | Global Antithrombotic Drugs Industry | Glob …
Antithrombotic drugs are special drugs that help to prevent the formation of thrombus or clot. These drugs are used to reduce the formation of blood clots by reducing the capability of body to form a blood clot. Antithrombotic drugs act by preventing the production of vitamin K in the liver. Anticoagulant, antiplatelet, and thrombolytic agents are different types of antithrombotic agents that act by different clotting processes. Arterial & venous…
Global HIV Drugs Market | Global HIV Drugs Industry | Global HIV Drugs Market Re …
Human immunodeficiency Virus (HIV) could be a chronic and severe sickness which might be transferred from one person to a different through blood-to-blood and sexual contact. it's a deadly disease that attacks immune cells called CD-4 cells, creating body vulnerable to infections and alternative diseases. Over the years, the rising prevalence of HIV sickness worldwide has completely influenced the demand for HIV medicine. HIV medicine facilitate in preventing the multiplication…
Hepatitis Drugs Market by Therapeutics, Diagnostics, Patient, Drugs Policy
The global hepatitis drugs market is growing due to increasing incidences of hepatitis and increasing support from government organizations. In addition, the growing geriatric population, and increasing R&D investments on hepatitis research and drug discovery are also driving the growth of the global hepatitis drugs market.
Access Detailed Report Summary: https://www.psmarketresearch.com/market-analysis/hepatitis-drugs-market
Among the various types, the hepatitis C segment is expected to be the largest segment, and expected to witness the fastest…
Epilepsy Drugs Market by Country, Drugs, Company & Forecast
For More Information:
https://renub-research.blogspot.com/2019/04/the-factors-that-are-driving-global.html
Epilepsy is a chronic disease in which patient’s brain activities become abnormal due to seizures. Seizure is an unexpected rush of electrical activity in the brain. Seizure is categorized by two types - generalized seizures and focal or partial seizures. Generalized seizures affect the whole brain whereas focal or partial seizures affect just one part of the brain. Global epilepsy drugs market is expected to cross US$…
